Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. QGEN
QGEN logo

QGEN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

QGEN News

Schall Law Firm Investigates Qiagen for Securities Violations

4d agoGlobenewswire

Qiagen to Announce Q1 Earnings on May 6

5d agoseekingalpha

Latest Wall Street Rating Updates

Apr 29 2026CNBC

Qiagen Faces Investigation for Potential Investor Claims

Apr 29 2026Globenewswire

U.S. Stocks Close Lower, Weighed Down by Tech Sector

Apr 28 2026NASDAQ.COM

US Stock Market Volatility Amid Economic Data

Apr 28 2026NASDAQ.COM

US Stocks Mostly Lower, Tech Sector Under Pressure

Apr 28 2026NASDAQ.COM

QIAGEN Lowers 2026 Sales Growth Forecast

Apr 27 2026stocktwits

QIAGEN Lowers 2026 Sales Growth Outlook Amid Q1 Results

Apr 27 2026seekingalpha

QIAGEN Files Annual Report for 2025

Mar 20 2026Newsfilter

New Study Supports QuantiFERON-TB Gold Plus Use in High-Risk Populations

Mar 19 2026Newsfilter

Key Wall Street Ratings Updates on Friday

Mar 13 2026CNBC

Wall Street Analysts Adjust NIO Ratings

Mar 13 2026Benzinga

FDA Approves GI Panels for QIAstat-Dx Rise Platform

Mar 10 2026Newsfilter

Qiagen CEO Actively Evaluating Strategic Alternatives

Mar 02 2026seekingalpha

Surge in Options Trading Volume for nLight and Qiagen

Feb 24 2026NASDAQ.COM